Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $787.66 billion, total revenue of $172.67 billion and a weighted average PE ratio of 43.94.
Market Cap
787.66B
Revenue
172.67B
Profits
17.93B
PE Ratio
43.94
Profit Margin
10.38%
Dividend Yield
0.21%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 212.23B | -0.66% | 610,640 | 46.34B |
| 2 | DHR | Danaher Corporation | 138.84B | -1.08% | 1,211,162 | 25.11B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 46.19B | 0.26% | 291,568 | 4.55B |
| 4 | A | Agilent Technologies, Inc. | 39.58B | -0.69% | 292,668 | 7.23B |
| 5 | WAT | Waters Corporation | 38.97B | -0.78% | 330,726 | 4.64B |
| 6 | NTRA | Natera, Inc. | 38.05B | -3.26% | 789,687 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 37.87B | -2.54% | 513,454 | 16.98B |
| 8 | ILMN | Illumina, Inc. | 28.69B | -4.94% | 1,758,822 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.30B | -0.63% | 40,133 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 26.15B | 0.47% | 241,875 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.53B | 0.27% | 135,976 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 21.37B | -2.42% | 557,288 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.19B | -1.32% | 51,530 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 12.57B | -2.02% | 393,997 | 2.91B |
| 15 | ICLR | ICON Public Limited Company | 12.38B | -1.87% | 210,603 | 8.29B |
| 16 | CRL | Charles River Laboratories International, Inc. | 12.36B | -0.67% | 401,146 | 4.00B |
| 17 | QGEN | Qiagen N.V. | 8.64B | -0.45% | 1,583,235 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 6.94B | -3.74% | 833,313 | 431.80M |
| 19 | SHC | Sotera Health Company | 5.40B | 5.39% | 2,589,736 | 1.22B |
| 20 | RDNT | RadNet, Inc. | 5.29B | 0.28% | 176,513 | 2.14B |
| 21 | BLLN | BillionToOne, Inc. | 4.27B | -39.68% | 2,569,794 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.78B | -3.70% | 649,218 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.72B | 0.28% | 353,285 | 561.90M |
| 24 | GRAL | GRAIL, Inc. | 2.84B | -14.40% | 1,110,758 | 165.26M |
| 25 | CDNA | CareDx, Inc. | 2.35B | -0.04% | 299,682 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.06B | -1.16% | 392,431 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.01B | -0.70% | 888,978 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.42B | -1.63% | 943,160 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.26B | 2.20% | 204,155 | 34.24M |
| 30 | OPK | OPKO Health, Inc. | 996.35M | -1.11% | 1,413,057 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 913.74M | -1.61% | 177,675 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 503.81M | -1.19% | 114,510 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 295.56M | -1.90% | 783,997 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 224.67M | -4.76% | 145,456 | 102.94M |
| 35 | XGN | Exagen Inc. | 160.42M | -0.15% | 229,032 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 156.28M | -3.20% | 22,133 | 1.95M |
| 37 | BNR | Burning Rock Biotech Limited | 94.28M | 0.68% | 1,054 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 40.52M | -3.45% | 25,826 | 25.83M |
| 39 | QUCY | Quantum Cyber N.V. | 32.33M | -2.07% | 302,002 | 537.08K |
| 40 | MDXH | MDxHealth SA | 22.35M | 0.37% | 63,546 | 110.97M |
| 41 | ADVB | Advanced Biomed Inc. | 12.59M | -4.03% | 38,800 | - |
| 42 | MBAI | Check-Cap Ltd. | 9.89M | -1.54% | 36,103 | - |
| 43 | XWEL | XWELL, Inc. | 9.04M | 7.00% | 13,513 | 28.83M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.86M | 1.54% | 3,269 | - |
| 45 | ISPC | iSpecimen Inc. | 3.18M | 15.10% | 301,050 | 1.03M |
| 46 | BIAF | bioAffinity Technologies, Inc. | 2.40M | -0.08% | 116,378 | 5.66M |